The Mutation of Venture Capital: Decoding "Cancer Capital"

By Anil Dash (Rewritten)

We are facing a critical moment where we must honestly discuss the state of venture capital. There is a profound gap between the public perception of VC—an investor providing capital to help a visionary founder scale a business—and the grim reality. Today, a small group of billionaire extremists are using the "VC" label as a smokescreen to push radical agendas, operating entirely without accountability.

"I’ve personally raised tens of millions of dollars in venture capital as a CEO and helped facilitate hundreds of millions more as an advisor and board member. I have sat in the rooms and attended the events where these people congregate."

This isn't a complaint from someone who was denied funding; it is an observation from an insider. I belong to the community of inventors and creators that these investors used to support back when they actually valued $\textit{innovation}$.

The Societal Toll

The "Cancer Capitalists" are the hidden engine behind many of the modern frustrations we see today:

• The aggressive imposition of massive data centers on local communities.
• The systemic enshittification of our favorite digital services.
• The financial incentivization of politicians to ignore the public will.

They have transformed VC into a form of oligarchy that is immune to market pressures, regulatory oversight, and the democratic process.

---

How Venture Capital Became "Cancer Capital"

To understand this evolution, we have to look at the biological metaphor. In a healthy economy, high-risk investment should be a small, specialized segment.

$\text{Healthy Portfolio} = \text{Stable Assets (Majority)} + \text{High-Risk VC (Minority)}$

However, like a cancer cell—which is a necessary cell that becomes lethal when it grows without restriction—VC has expanded until it threatens the host.

The Evolution of the Model

The Math of Insulated Wealth

As regulations loosened, "do-everything" funds emerged, blending private equity with VC. When a firm manages massive sums, the risk disappears for the managers.

If a firm manages a fund of \50\text{ billion}$and charges a standard$2% management fee: $$\50,000,000,000 \times 0.02 = $1,000,000,000$$

The partners pocket one billion dollars annually regardless of whether the startups they funded succeed or fail.

---

The New Power Dynamics

The balance of power has completely flipped. Founders build companies that VCs want to fund. Now, VCs publish ideological manifestos, and "founders" are simply the agents hired to execute those visions.

The Great Deception

• New Talent: Young workers enter tech thinking the "old rules" apply, wondering why their ideas are being twisted to serve the goals of a few tycoons.
• The Establishment: Politicians and media outlets still view VC through a 20-year-old lens, praising them for "job creation" while the tycoons are actually just hoarding power.

---

Financial Engineering and the Public Burden

The corruption extends to how these funds are financed and exited.

The "Bag-Holding" Pipeline

• Pension Fund Integration: Funding now flows from retail retirement accounts.
• Risk Shift: The general public now carries the actual risk of the portfolio.
• IPO Avoidance: Firms cash out via secondary markets long before a company goes public.
• Profit Illusion: They make massive returns on companies that never actually turn a profit.

The Post-VC Loophole

Because these entities are no longer legally classified as "venture capital firms," they can engage in maneuvers that were previously forbidden:

1. Buying shares directly from founders.
2. Holding unlimited public stock.
3. Internal Asset Flipping: Selling an investment from one of their funds to another.

def book_fake_profit(asset_value, internal_transfer_price):
    # The company hasn't grown, but the fund books a gain
    profit = internal_transfer_price - asset_value
    return f"Booked Profit: ${profit} (No actual value created)"

print(book_fake_profit(1000000, 5000000))

By manipulating these internal transfers, Cancer Capital firms can report massive gains to their investors without the underlying company ever achieving a single cent of real-world profitability.